The levels of VEGFR-2+-CEPs and mature circulating endothelial cells (CECs), the latter possibly derived from tumor endothelium by vascular turnover [109], found in peripheral blood before and after tumor treatment could help to explain vascularization and tumor progression and the biological activity of a therapeutic agent [110,111]. This evidence concerns the gene KDR and neoplasm.